The off-label use of prescription drugs in the United States is extremely common. Studies reveal that as much as 1 in 5 prescriptions are not used for their approved use by the Food & drug Administration. A new study reports that physician’s who prescribe drugs for off-label use are being paid to promote the drug. …
211 participants in clinical trials in India died from January to June of 2012 due to serious adverse events (SAE). Investigations are now on to ascertain how many of the deaths were caused by drugs administered to the trial subjects. Union health minister Ghulam Nabi Azad has said that the deaths could be related to …
If you’re concerned about breast cancer, you may be wondering if there are steps you can take toward breast cancer prevention, and thankfully, there actually are. Just by understanding the lifestyle factors that may affect your risk of breast cancer and what you can do to stay healthy, is a start in the right direction. …
Pulmonary hypertension is high blood pressure in the arteries to your lungs. It is a rare lung disorder in which the arteries that carry blood from the heart to the lungs become narrowed. Pulmonary hypertension can cause the heart to overwork and become enlarged. This can eventually lead to heart failure. Treating pulmonary hypertension involves …
Can a drug have side effects that don’t appear for over a decade? The answer is yes! Even though you may not see any current adverse events, there are some medications that can cause terrible effects, years and years after initial ingestion. In a lawsuit alleging that the diet drug fen-phen caused pulmonary hypertension in a young woman, …
In June 2011 the Federal Drug Administration (FDA) added a serious warning to the label on a widely prescribed drug for men called Avodart. This medication is one of a class of drugs called 5-alpha reductase inhibitors linked to an increased risk of high-grade prostate cancer. What Is Avodart? Avodart is the brand name of …
A former Abbott Laboratories sales rep filed a federal lawsuit against the company, accusing it of illegally promoting its cholesterol drug TriCor for uses not approved by regulators, including the prevention of cardiac health risks in patients with diabetes. The suit was filed in September 2009 in U.S. District Court in the Eastern District of Pennsylvania by …